General information

TURNOVER:

Revenue (in thousands of €)

 

GROWTH IN RECENT YEARS:

Laboratorios Rubió is a company that is currently undergoing a process of expansion and growth. In the last 5 years, the continued advances are an indication of the hard work put in, and the implementation of a strategy (2014-2018) that shifts the focus towards identifying new business segments, opening new markets and signing distribution agreements with other companies in the pharmaceutical sector.

In 2017, revenue reached € 30,7 million, which is 20,1% more than in 2016. By market, the increase in Spain was one of 21,1%, with 0,9% growth in exports.

If we compare 2017 with the 2014 period, the increase in revenue is 47%, with 59% corresponding to the national market, and 7% to the international market.

The growth we hope to achieve in 2018 is 15,2%, which is brought about by sales in the national market.

 

EMPLOYEES:

The company’s staff is made up of 148 people—15,6% more than in 2014—with the greatest amount of growth happening in the sales and industrial operations departments.

Laboratorios Rubió is a company that places its trust in the people who make up its organisation, recognises their professional value and dedicates resources to ensure that a good working environment is maintained by fostering opportunities, personal development and a good work-life balance.

GENERAL INVESTMENTS:

In the last 5 years, including the 2018 budget, total investment reached € 8,9 million, of which € 2.9 million are industrial investments, € 857 thousand have been invested in to IT and new technology and € 5,2 million into different projects such as the development of new pharmaceutical formulations, sales agreements in the US with an American partner, and the liposcale project with our investee company, Biosfer.

Investments (in thousands of €)